19-49635602-C-T
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006270.5(RRAS):c.631G>A(p.Gly211Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000772 in 1,438,128 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006270.5 missense
Scores
Clinical Significance
Conservation
Publications
- Noonan syndrome and Noonan-related syndromeInheritance: AD Classification: STRONG Submitted by: G2P
- Noonan syndromeInheritance: AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RRAS | NM_006270.5 | c.631G>A | p.Gly211Arg | missense_variant | Exon 6 of 6 | ENST00000246792.4 | NP_006261.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000990 AC: 15AN: 151538Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000588 AC: 9AN: 152940 AF XY: 0.0000370 show subpopulations
GnomAD4 exome AF: 0.0000746 AC: 96AN: 1286590Hom.: 1 Cov.: 31 AF XY: 0.0000812 AC XY: 51AN XY: 627864 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000990 AC: 15AN: 151538Hom.: 0 Cov.: 31 AF XY: 0.000135 AC XY: 10AN XY: 73946 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:2
- -
The c.631G>A (p.G211R) alteration is located in exon 6 (coding exon 6) of the RRAS gene. This alteration results from a G to A substitution at nucleotide position 631, causing the glycine (G) at amino acid position 211 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Noonan syndrome Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 211 of the RRAS protein (p.Gly211Arg). This variant is present in population databases (rs369588682, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with RRAS-related conditions. ClinVar contains an entry for this variant (Variation ID: 582576). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at